Article
Allogeneic stem cell transplantation in paroxysmal nocturnal hemoglobinuria
11 Jun 2012
Abstract excerpt
BACKGROUND: In the era of eculizumab, identifying patients with paroxysmal nocturnal hemoglobinuria who may benefit from allogeneic stem cell transplantation is challenging. DESIGN AND METHODS: We describe the characteristics and overall survival of 211 patients transplanted for paroxysmal nocturnal hemoglobinuria in 83 EBMT centers from 1978 to 2007. Next, we conducted a comparison with a cohort of 402...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
